Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-16-106769)

Filing Details

Accession Number:: 0001144204-16-106769
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-06-03 16:16:01
Reporting Period:: 2016-06-03

Filing Date:: 2016-06-03
Accepted Time:: 2016-06-03 16:16:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1430306	Tonix Pharmaceuticals Holding Corp.	TNXP	Pharmaceutical Preparations (2834)	261434750

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610106	M Gregory Sullivan	C/O Tonix Pharmaceuticals Holdings Corp 509 Madison Ave., Suite 306 New York NY 10022	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2016-06-03	20,000	$2.50	43,185	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $2.495815. The range of purchase prices on the transaction date was $2.48 to $2.52 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.